Antipsychotics Flashcards
Antipsychotic with the largest effect on EEG
Clozapine
Antipsychotic with the lowest effect on EEGs
Quetiapine
Receptor thought to mediate the erectile dysfunction side effects of antipsychotics
Cholinergic receptor antagonism
Causes of sexual dysfunction in antipsychotic use
Due to elevated prolactin levels
Anticholinergic and antiadrenergic effects independent of prolactin levels
Antipsychotics with greatest prolactin elevation
Risperidone/paliperidone
Antipsychotics with the greatest impact on sexual function
Risperidone/paliperidone
Haloperidol
Percentage of patients taking haloperidol and risperidone/paliperidone who report sexual dysfunction
70%
Antipsychotics with lowest sexual dysfunction effects
Aripiprazole
Asenapine
Lurasidone
Proposed mechanisms of action of antipsychotic related weight gain
5HT2A and 5HT2C antagonism D2 and D3 antagonism H1 antagonism M3 antagonism Hyperprolactinaemia Increased serum leptin leading to leptin desensitisation Ghrelin
Antipsychotics with high risk of weight gain
Clozapine
Olanzapine
Antipsychotics with moderate risk of weight gain
Chlorpromazine
Quetiapine
Risperidone
Paliperidone
Antipsychotics with low risk of weight gain
Amisulpride Asenapine Aripiprazole Haloperidol Sulpride Lurasidone Ziprasidone
Antipsychotic which has been seen to cause weight loss when used with clozapine or olanzapine
Aripiprazole
Antipsychotic associated weight gain liraglutide can be used for
Clozapine
Typical antipsychotic felt to be most effective in depot form - possibly with higher side effects
Zuclopenthixol
Atypical antipsychotics available in depot form
Risperidone - as risperdal consta or paliperidone
Olanzapine
Aripiprazole
Requirement for test dosing with depot antipsychotics
Always required for first generation antipsychotics
Should be considered for second generation antipsychotics if it is not clear if an oral dose has been taken
Base of second generation antipsychotic depot medications which is not known to be allergenic
Aqeous
Time during depot dosing when patients may be at highest risk of a relapse
Immediately after a depot dose
Time after withdrawing an antipsychotic depot when relapse occurs in trails
3-6 months after stopping
Site into which olanzapine depot must be injected
Gluteal
Cause of post injection syndrome in giving antipsychotic depots
Accidental entry into a blood vessel on administration
Features of post injection syndrome
Sedation Confusion Dizziness Agitation/aggression EPSEs HTN Convulsion
Typical antipsychotics
Chlorpromazine Flupenthixol Zuclopenthixol Perphenazine Sulpride Haloperidol
Atypical antipsychotics
Clozapine Risperidone Olanzapine Quetiapine Ziprasidone Amisulpride Aripiprazole
Active metabolite of thioridazine
Mesoridazine
Base of first generation antipsychotic medications
Coconut oil or sesame oil
Time after injection when depot flupentixol reaches peak levels
3-7 days
Time after injection when depot fluphenazine reaches peak levels
24 hours
Time after injection when depot haloperidol reaches peak levels
7 days